← Browse by Condition
Medical Condition

cardiac arrest

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for cardiac arrest sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cardiac arrest Clinical Trials

How many clinical trials are currently recruiting for cardiac arrest?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for cardiac arrest, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cardiac arrest?
cardiac arrest research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cardiac arrest clinical trial?
Eligibility criteria for cardiac arrest trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
St. Olavs Hospital 1 trial
Azienda Usl di Bologna 1 trial
Maastricht University Medical Center 1 trial
Children's Hospital of Philadelphia 1 trial
Erasme University Hospital 1 trial

Recruiting Clinical Trials

NCT06672159
Recruiting

Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest

Enrollment
356 pts
Location
Norway
Sponsor
St. Olavs Hospital
View Trial →
NCT06395558
Recruiting

intErnet-based iNterventions FOR Cardiac arrEst suRvivors

Enrollment
106 pts
Location
Italy
Sponsor
Azienda Usl di Bologna
View Trial →
NCT06766006
Recruiting

ECMO LEft Ventricle UNloading Strategy

Enrollment
500 pts
Location
Netherlands
Sponsor
Maastricht University Medical ...
View Trial →
NCT02708134
Recruiting

Quality of Pediatric Resuscitation in a Multicenter Collaborative

Enrollment
7,000 pts
Location
United States, Austr...
Sponsor
Children's Hospital of Philade...
View Trial →
NCT05004610 Phase 2
Recruiting

Hypertonic Lactate After Cardiac Arrest

Enrollment
125 pts
Location
Belgium
Sponsor
Erasme University Hospital
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology